Cite
APA Citation
Aoki, M., Shoji, H., Nagashima, K., Imazeki, H., Miyamoto, T., Hirano, H., Honma, Y., Iwasa, S., Okita, N., Takashima, A., Kato, K., Higuchi, K., & Boku, N. (2019). hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer. ESMO open, 4(3), . http://access.bl.uk/ark:/81055/vdc_100127559076.0x000019